Hematology

A phase 3 clinical trial, explorer8, has demonstrated the efficacy and safety of concizumab…

A phase 3 clinical trial, explorer8, has demonstrated the efficacy and safety of concizumab…

A recent international clinical trial involving 850 patients has revealed that a liberal blood transfusion strategy significantly improves neurological outcomes…

A ground-breaking study has identified circulating cell-free DNA as a potential biomarker for predicting early relapse in patients with aggressive B-cell lymphoma…

A new study shows that adding itacitinib to standard GvHD prophylaxis in haplo-HCT is safe and well-tolerated.

A study has revealed that cognitive decline in older adults diagnosed with hematologic malignant neoplasms is similar to the cognitive decline in normal ageing…

A recent study highlights an increased risk of thromboembolic events in metastatic lung cancer patients treated with immune checkpoint inhibitors…

The new strategy converts CDKs into targeted activators of cancer-specific genes that promote cell death…